Alzheimer’s Association Welcomes FDA Advisory Committee Unanimous Vote of Efficacy of Donanemab for the Treatment of Early Alzheimer’s Disease

Recognizing AIM’s June Advocate of the Month: John Mathis

Senate HELP Committee Advances BOLD Legislation to Renew Nation’s Commitment to Dementia Public Health Infrastructure